| Year |
Title |
Altmetric |
| 2021
|
Puma, noxa, p53, and p63 differentially mediate stress pathway induced apoptosis.
Cell Death and Disease.
12.
2021
|
|
| 2020
|
Human transcription factors responsive to initial reprogramming predominantly undergo legitimate reprogramming during fibroblast conversion to iPSCs.
Scientific Reports.
10.
2020
|
|
| 2019
|
Truncating PKHD1 and PKD2 mutations alter energy metabolism
2019
|
|
| 2016
|
Observing mitotic division and dynamics in a live zebrafish embryo.
Journal of Visualized Experiments.
2016.
2016
|
|
| 2016
|
Mutation of Growth Arrest Specific 8 Reveals a Role in Motile Cilia Function and Human Disease.
PLoS Genetics.
12.
2016
|
|
| 2016
|
Approaches to inactivate genes in zebrafish.
Advances in Experimental Medicine and Biology.
916:61-86.
2016
|
|
| 2015
|
Erratum: Activity suppression behavior phenotype in SULT4A1 frameshift mutant zebrafish (Drug Metabolism and Disposition (2015) 43 (1037-1044)).
Drug Metabolism and Disposition.
43:1284.
2015
|
|
| 2015
|
Activity suppression behavior phenotype in SULT4A1 frameshift mutant zebrafish.
Drug Metabolism and Disposition.
43:1037-1044.
2015
|
|
| 2015
|
Variations in dysfunction of sister chromatid cohesion in esco2 mutant zebrafish reflect the phenotypic diversity of Roberts syndrome
2015
|
|
| 2014
|
High-throughput genome editing and phenotyping facilitated by high resolution melting curve analysis.
PLoS ONE.
9.
2014
|
|
| 2014
|
Inhibition of sult4a1 expression induces up-regulation of phototransduction gene expression in 72-hour postfertilization zebrafish larvae.
Drug Metabolism and Disposition.
42:947-953.
2014
|
|
| 2010
|
Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair.
Oncogene.
29:6125-6137.
2010
|
|
| 2010
|
Genetic modeling of Li-Fraumeni syndrome in zebrafish
2010
|
|
| 2009
|
A rapid and efficient method of genotyping zebrafish mutants.
Developmental Dynamics.
238:3168-3174.
2009
|
|
| 2008
|
EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model.
Cancer Research.
68:8968-8975.
2008
|
|
| 2008
|
Targeted disruption of Aurora A causes abnormal mitotic spindle assembly, chromosome misalignment and embryonic lethality.
Oncogene.
27:4122-4127.
2008
|
|
| 2008
|
Mtbp haploinsufficiency in mice increases tumor metastasis.
Oncogene.
27:1813-1820.
2008
|
|
| 2007
|
The Tol2kit: A multisite gateway-based construction Kit for Tol2 transposon transgenesis constructs.
Developmental Dynamics.
236:3088-3099.
2007
|
|
| 2006
|
Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4.
Molecular and Cellular Biology.
26:192-198.
2006
|
|
| 2005
|
Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor
2005
|
|
| 2004
|
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.
Cell.
119:861-872.
2004
|
|
| 2004
|
Mutation at p53 serine 389 does not rescue the embryonic lethality in mdm2 or mdm4 null mice.
Oncogene.
23:7644-7650.
2004
|
|
| 2004
|
Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice.
Nature Genetics.
36:63-68.
2004
|
|
| 2003
|
Switching Mechanisms of Cell Death in mdm2- and mdm4-null Mice by Deletion of p53 Downstream Targets.
Cancer Research.
63:8664-8669.
2003
|
|
| 2003
|
Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.
Cell.
112:779-791.
2003
|
|
| 2003
|
Disrupting TP53 in mouse models of human cancers.
Human Mutation.
21:321-326.
2003
|
|
| 2002
|
Mutual dependence of MDM2 and MDMX in their functional inactivation of p53.
Journal of Biological Chemistry.
277:19251-19254.
2002
|
|
| 2001
|
Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53.
Nature Genetics.
29:92-95.
2001
|
|
| 2001
|
Organization, expression, and localization of the murine mdmx gene and pseudogene.
Gene.
270:277-283.
2001
|
|
| 2001
|
Differential roles of p21Waf1 and p27Kip1 in modulating chemosensitivity and their possible application in drug discovery studies.
Molecular Pharmacology.
60:900-906.
2001
|
|
